SCI Abstract

search
Cancers, Vol. 15, Pages 188: Immunohistochemical Study of Bladder Cancer Molecular Subtypes and Their Association with PD-L1 Expression
Cancers, Vol. 15, Pages 188: Immunohistochemical Study of Bladder Cancer Molecular Subtypes and Their Association with PD-L1 Expression
The significant heterogeneity in clinical outcomes among patients with bladder cancer has highlighted the existence of dif...
Cancers, Vol. 15, Pages 179: Targeted Therapy for Anaplastic Thyroid Carcinoma: Advances and Management
Cancers, Vol. 15, Pages 179: Targeted Therapy for Anaplastic Thyroid Carcinoma: Advances and Management
Anaplastic thyroid carcinoma (ATC) is a rare and highly fatal cancer with the worst prognosis of all thyroid carcinoma (TC...
Cancers, Vol. 15, Pages 186: Clinical Significance of Glycolytic Metabolic Activity in Hepatocellular Carcinoma
Cancers, Vol. 15, Pages 186: Clinical Significance of Glycolytic Metabolic Activity in Hepatocellular Carcinoma
High metabolic activity is a hallmark of cancers, including hepatocellular carcinoma (HCC). However, the molecular feature...
Cancers, Vol. 15, Pages 183: Molecular Basis of HER2-Targeted Therapy for HER2-Positive Colorectal Cancer
Cancers, Vol. 15, Pages 183: Molecular Basis of HER2-Targeted Therapy for HER2-Positive Colorectal Cancer
Human epidermal growth factor receptor 2 (HER2) amplification has emerged as a biomarker in colorectal cancer (CRC), occur...
Cancers, Vol. 15, Pages 173: Immune Checkpoint Inhibitors and Pregnancy: Analysis of the VigiBase® Spontaneous Reporting System
Cancers, Vol. 15, Pages 173: Immune Checkpoint Inhibitors and Pregnancy: Analysis of the VigiBase® Spontaneous Reporting System
In pregnancy, immune checkpoint pathways are involved in the maintenance of fetomaternal immune tolerance. Preclinical stu...
Cancers, Vol. 15, Pages 181: Histopathological Growth Pattern in Colorectal Liver Metastasis and The Tumor Immune Microenvironment
Cancers, Vol. 15, Pages 181: Histopathological Growth Pattern in Colorectal Liver Metastasis and The Tumor Immune Microenvironment
Almost half of all patients with colorectal cancer present with or eventually develop metastasis, most frequently in the l...
Cancers, Vol. 15, Pages 135: The FDA-Approved Drug Pyrvinium Selectively Targets ER+ Breast Cancer Cells with High INPP4B Expression
Cancers, Vol. 15, Pages 135: The FDA-Approved Drug Pyrvinium Selectively Targets ER+ Breast Cancer Cells with High INPP4B Expression
The majority of breast cancers are estrogen receptor-positive (ER+), and endocrine therapies that suppress ER signaling ar...
Cancers, Vol. 15, Pages 140: Blood Plasma Metabolome Profiling at Different Stages of Renal Cell Carcinoma
Cancers, Vol. 15, Pages 140: Blood Plasma Metabolome Profiling at Different Stages of Renal Cell Carcinoma
Early diagnostics significantly improves the survival of patients with renal cell carcinoma (RCC), which is the prevailing...
Cancers, Vol. 15, Pages 134: Research Progress and Direction of Novel Organelle—Migrasomes
Cancers, Vol. 15, Pages 134: Research Progress and Direction of Novel Organelle—Migrasomes
Migrasomes are organelles that are similar in structure to pomegranates, up to 3 μm in diameter, and contain small ...
Cancers, Vol. 15, Pages 131: Sulfatase 2 Affects Polarization of M2 Macrophages through the IL-8/JAK2/STAT3 Pathway in Bladder Cancer
Cancers, Vol. 15, Pages 131: Sulfatase 2 Affects Polarization of M2 Macrophages through the IL-8/JAK2/STAT3 Pathway in Bladder Cancer
Sulfatase 2 (SULF2) affects the occurrence and development of cancer by regulating HSPG-binding factors. However, the mech...
Cancers, Vol. 15, Pages 138: Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies
Cancers, Vol. 15, Pages 138: Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies
Post-translational modifications (PTMs) are generated by adding small chemical groups to amino acid residues after the tra...
Cancers, Vol. 15, Pages 136: Time for Dynamic Assessment of Fitness in Acute Myeloid Leukemia
Cancers, Vol. 15, Pages 136: Time for Dynamic Assessment of Fitness in Acute Myeloid Leukemia
Informed treatment decision-making in acute myeloid leukemia (AML) requires a comprehensive evaluation of all clinical and...
Cancers, Vol. 15, Pages 147: Activin B and Activin C Have Opposing Effects on Prostate Cancer Progression and Cell Growth
Cancers, Vol. 15, Pages 147: Activin B and Activin C Have Opposing Effects on Prostate Cancer Progression and Cell Growth
Current prognostic and diagnostic tests for prostate cancer are not able to accurately distinguish between aggressive and ...
Cancers, Vol. 15, Pages 113: The Effects of Heat Stress on the Transcriptome of Human Cancer Cells: A Meta-Analysis
Cancers, Vol. 15, Pages 113: The Effects of Heat Stress on the Transcriptome of Human Cancer Cells: A Meta-Analysis
Hyperthermia is clinically applied cancer treatment in conjunction with radio- and/or chemotherapy, in which the tumor vol...
Cancers, Vol. 15, Pages 118: 5-Azacytidine-Mediated Modulation of the Immune Microenvironment in Murine Acute Myeloid Leukemia
Cancers, Vol. 15, Pages 118: 5-Azacytidine-Mediated Modulation of the Immune Microenvironment in Murine Acute Myeloid Leukemia
Cancer cells accumulate epigenetic modifications that allow escape from intrinsic and extrinsic surveillance mechanisms. I...
Cancers, Vol. 15, Pages 126: Current Biological, Pathological and Clinical Landscape of HER2-Low Breast Cancer
Cancers, Vol. 15, Pages 126: Current Biological, Pathological and Clinical Landscape of HER2-Low Breast Cancer
HER2-low breast cancer (BC) is a newly defined subset of HER2-negative BC that has HER2 immunohistochemical (IHC) score of...